These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8016889)

  • 1. The effect of intravenous immunoglobulin and interferon-alpha on Epstein-Barr virus-induced lymphoproliferative disorder in a liver transplant recipient.
    Taguchi Y; Purtilo DT; Okano M
    Transplantation; 1994 Jun; 57(12):1813-5. PubMed ID: 8016889
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic active Epstein-Barr virus infection in an adult.
    Sakamoto T; Uemura M; Fukui H; Yoshikawa M; Fukui K; Kinoshita K; Kojima H; Matsumori T; Tsujii T; Sumazaki R
    Intern Med; 1992 Oct; 31(10):1190-6. PubMed ID: 1337484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children.
    Votava M; Bartosová D; Krchnáková A; Crhová K; Kubinová L
    Acta Virol; 1996 Apr; 40(2):99-101. PubMed ID: 8886119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal Epstein-Barr virus-associated lymphoproliferative disorder in childhood.
    Yatabe Y; Mori N; Oka K; Iijima T; Saga S; Takada K; Asai J
    Arch Pathol Lab Med; 1995 May; 119(5):409-17. PubMed ID: 7748067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for visceral leishmaniasis: role of Epstein-Barr virus infection.
    Louzir H; Triki H; Bennani S; Edelman L; Laouini D; Ben Ismail R; Joab I; Dellagi K
    Arch Inst Pasteur Tunis; 1993; 70(3-4):357-62. PubMed ID: 7802490
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of 2 fluorescence assays for the diagnosis of Epstein-Barr virus infections].
    de Ory F; Guisasola ME
    Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):442-3. PubMed ID: 9887641
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients.
    Smets F; Bodeus M; Goubau P; Reding R; Otte JB; Buts JP; Sokal EM
    J Hepatol; 2000 Jan; 32(1):100-4. PubMed ID: 10673073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of Epstein-Barr virus serology in children after liver transplant: lack of clinical correlation.
    Granot E; Doron D; Morag R
    Transplant Proc; 2000 Jun; 32(4):706-7. PubMed ID: 10856551
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic evaluation of a new panel of assays for Epstein-Barr virus serology.
    Radtke M; Gärtner B; Franke D
    Clin Lab; 2007; 53(3-4):149-50. PubMed ID: 17447650
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-transplant lymphoproliferative disorder.
    Basgoz N; Preiksaitis JK
    Infect Dis Clin North Am; 1995 Dec; 9(4):901-23. PubMed ID: 8747772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease.
    Montone KT; Hodinka RL; Salhany KE; Lavi E; Rostami A; Tomaszewski JE
    Mod Pathol; 1996 Jun; 9(6):621-30. PubMed ID: 8782198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBV-induced post-transplant lymphoproliferative disorder (PTLD).
    Birkeland SA; Hamilton-Dutoit S; Sandvej K; Andersen HM; Bendtzen K; Møller B; Jørgensen KA
    Transplant Proc; 1995 Dec; 27(6):3467-72. PubMed ID: 8540055
    [No Abstract]   [Full Text] [Related]  

  • 13. Hematologic consequences of Epstein-Barr virus infection.
    Sullivan JL
    Hematol Oncol Clin North Am; 1987 Sep; 1(3):397-417. PubMed ID: 2834314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between Epstein-Barr virus and lymphoproliferative syndromes in patients without immunodeficiency].
    Barranco M; Vidal J; Quintero L; Vives-Corrons JL; Jiménez de Anta MT
    Sangre (Barc); 1995 Oct; 40(5):383-7. PubMed ID: 8553172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epstein-Barr virus associated lymphoproliferative syndrome after liver transplantation].
    Gutiérrez Junquera C; Moreno Villares JM; Medina Benítez E; Urruzuno Tellería P; Fuertes Ortiz A; Colina Ruiz-Delgado F; Manzanares López-Manzanares J
    An Esp Pediatr; 1992 Aug; 37(2):157-60. PubMed ID: 1329596
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoregulatory abnormalities in patients with Epstein-Barr virus-associated B cell lymphoproliferative disorders.
    Mathur A; Kamat DM; Filipovich AH; Steinbuch M; Shapiro RS
    Transplantation; 1994 Apr; 57(7):1042-5. PubMed ID: 8165700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual case of Epstein-Barr virus DNA tissue positive: blood negative in a patient with post-transplant lymphoproliferative disorder.
    Levenson BM; Ali SA; Timmons CF; Mittal N; Muthukumar A; Payne DA
    Pediatr Transplant; 2009 Feb; 13(1):134-8. PubMed ID: 18482217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus in pediatric patients after renal transplantation.
    Schwab M; Böswald M; Korn K; Ruder H
    Clin Nephrol; 2000 Feb; 53(2):132-9. PubMed ID: 10711415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy.
    Cheng FW; Lee V; To KF; Chan KC; Shing MK; Li CK
    Pediatr Blood Cancer; 2009 Dec; 53(7):1329-31. PubMed ID: 19591223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epstein-Barr virus infection and lymphoproliferative disorders in patients after renal transplantation].
    Merlino C; Giacchino F; Tognarelli G; Cavallo R; Re D; Sinesi F; Segoloni G; Negro Ponzi A
    Minerva Urol Nefrol; 1996 Sep; 48(3):139-43. PubMed ID: 8966650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.